<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:35:52" record="18251" source="Espacenet">
	<entities>
		<entity ref="Patent18251" type="Patent">
			<semanticIdentifier>brcris::948e99974cbe22761a62cf001db8cf21</semanticIdentifier>
			<semanticIdentifier>docdb::BR102018071551A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102018071551</semanticIdentifier>
			<semanticIdentifier>docdb::BR102018071551A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20181071551</semanticIdentifier>
			<semanticIdentifier>original::102018071551</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102018071551"/>
			<field name="identifier.lattes" value="4178667286777514"/>
			<field name="identifier.espacenet" value="102018071551"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="compostos, uso de compostos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo 7,11b-dihydro-6h-indeno[2,1-c]chromene-3,6a,9,10-tetrol, seus derivados ou análogos, neutros ou ionizados, para prevenção e/ou terapia senolítica"/>
			<field name="title.lattes" value="COMPOSTOS, USO DE COMPOSTOS NA PREPARAÇÃO DE UMA COMPOSIÇÃO FARMACÊUTICA E COMPOSIÇÃO FARMACÊUTICA COMPREENDENDO 7,11B-DIHYDRO-6H-INDENO[2,1-C]CHROMENE- 3,6A,9,10-TETROL, SEUS DERIVADOS OU ANÁLOGOS, NEUTROS OU  IONIZADOS, PARA PREVENÇÃO E/OU TERAPIA SENOLÍTICA"/>
			<field name="depositDate" value="2018-10-19"/>
			<field name="publicationDate" value="2020-04-28"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="ANDRE ARIGONY SOUTO"/>
			<field name="inventor" value="GIOVANA RAVIZZONI ONZI"/>
			<field name="inventor" value="GUIDO LENZ"/>
			<field name="inventor" value="PRISCYLLA ANDRADE VOLKART"/>
			<field name="applicant" value="UNIAO BRASILEIRA DE EDUCACAO E ASSISTENCIA - MANTENEDORA DA PUCRS"/>
			<field name="applicant" value="UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K31/34AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="34AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K36/48AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="36"/>
				<field name="subgroup" value="48AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61P3/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="3"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61P9/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="A61P27/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="27"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="abstract.espacenet" value="a presente invenção descreve os compostos, o uso dos compostos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os compostos de fórmula a, seus derivados ou análogos, neutros ou ionizados, para prevenção e/ou terapia senolítica. especificamente, a presente invenção compreende os compostos, o uso dos compostos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os compostos de fórmula a, seus derivados ou análogos, neutros ou ionizados, para prevenção e/ou terapia senolítica, por meio de eliminação seletiva de células senolíticas."/>
			<field name="originatesFrom" value="70284176"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102018071551"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102018071551"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102018071551"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20181071551"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102018071551"/>
				<field name="kind" value=""/>
			</field>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=WO2020077428"/>
		</entity>
		<entity ref="Person12630" type="Person">
			<semanticIdentifier>lattes::4178667286777514</semanticIdentifier>
			<field name="identifier.lattes" value="4178667286777514"/>
			<field name="name" value="Guido Lenz"/>
		</entity>
		<entity ref="OrgUnit9844" type="OrgUnit">
			<semanticIdentifier>brcris::d2de58bb9f0b3621bfb3931e2401279b</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL"/>
		</entity>
		<entity ref="Patent18252" type="Patent">
			<semanticIdentifier>epodoc::WO2020077428</semanticIdentifier>
			<field name="countryCode" value="WO"/>
			<field name="originatesFrom" value="70284176"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="WO"/>
				<field name="number" value="WO2020077428"/>
				<field name="kind" value=""/>
			</field>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent18251" toEntityRef="Person12630" type="Inventor"/>
		<relation fromEntityRef="Patent18251" toEntityRef="OrgUnit9844" type="Applicant"/>
	</relations>
</entity-relation-data>
